Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Liisa Bayko is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/21/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/14/2025 | CRSP | Buy Now | CRISPR Therapeutics | $41.35 | 139.42% | Liisa Bayko70% | $60 → $99 | Upgrade | In-Line → Outperform | Get Alert |
| 02/12/2025 | TVTX | Buy Now | Travere Therapeutics | $20.55 | 118.98% | Liisa Bayko70% | $33 → $45 | Maintains | Outperform | Get Alert |
| 01/13/2025 | BCRX | Buy Now | BioCryst Pharma | $7.99 | 50.19% | Liisa Bayko70% | $10 → $12 | Maintains | Outperform | Get Alert |
| 12/16/2024 | EDIT | Buy Now | Editas Medicine | $1.31 | 281.68% | Liisa Bayko70% | $7 → $5 | Maintains | Outperform | Get Alert |
| 12/11/2024 | CARM | Buy Now | CARISMA Therapeutics | $0.42 | 68.35% | Liisa Bayko70% | $4 → $0.7 | Downgrade | Outperform → In-Line | Get Alert |
| 11/13/2024 | SVRA | Buy Now | Savara | $2.86 | 74.83% | Liisa Bayko70% | $7 → $5 | Downgrade | Outperform → In-Line | Get Alert |
| 10/30/2024 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $23.36 | 49.83% | Liisa Bayko70% | $30 → $35 | Maintains | Outperform | Get Alert |
| 10/23/2024 | EDIT | Buy Now | Editas Medicine | $1.31 | 129.01% | Liisa Bayko70% | $7 → $3 | Maintains | In-Line | Get Alert |
| 08/08/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $341.62 | 5.38% | Liisa Bayko70% | $405 → $360 | Maintains | Outperform | Get Alert |
| 06/25/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $283.34 | -8.24% | Liisa Bayko70% | $210 → $260 | Maintains | Outperform | Get Alert |
| 06/18/2024 | AVTE | Buy Now | Aerovate Therapeutics | $2.52 | -20.63% | Liisa Bayko70% | $27 → $2 | Downgrade | Outperform → In-Line | Get Alert |
| 05/30/2024 | EDIT | Buy Now | Editas Medicine | $1.31 | 434.35% | Liisa Bayko70% | $15 → $7 | Maintains | In-Line | Get Alert |
| 05/16/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 43.88% | Liisa Bayko70% | $7 → $2 | Maintains | In-Line | Get Alert |
| 05/15/2024 | ETNB | Buy Now | 89bio | $8.53 | 286.87% | Liisa Bayko70% | $37 → $33 | Maintains | Outperform | Get Alert |
| 05/15/2024 | AKRO | Buy Now | Akero Therapeutics | $44.94 | -15.44% | Liisa Bayko70% | $50 → $38 | Maintains | Outperform | Get Alert |
| 04/24/2024 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $23.36 | 28.42% | Liisa Bayko70% | $25 → $30 | Maintains | Outperform | Get Alert |
| 04/11/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -12.81% | Liisa Bayko70% | → $438 | Upgrade | In-Line → Outperform | Get Alert |
| 03/20/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $341.62 | 18.55% | Liisa Bayko70% | $325 → $405 | Maintains | Outperform | Get Alert |
| 03/07/2024 | ETNB | Buy Now | 89bio | $8.53 | 333.76% | Liisa Bayko70% | $29 → $37 | Maintains | Outperform | Get Alert |
| 03/06/2024 | ETNB | Buy Now | 89bio | $8.53 | 333.76% | Liisa Bayko70% | $29 → $37 | Maintains | Outperform | Get Alert |
| 02/12/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 403.6% | Liisa Bayko70% | $25 → $7 | Downgrade | Outperform → In-Line | Get Alert |
| 02/06/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -12.81% | Liisa Bayko70% | $436 → $438 | Downgrade | Outperform → In-Line | Get Alert |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $20.55 | -31.87% | Liisa Bayko70% | $30 → $14 | Maintains | Outperform | Get Alert |
| 09/19/2023 | TVTX | Buy Now | Travere Therapeutics | $20.55 | 45.99% | Liisa Bayko70% | $30 → $30 | Maintains | Outperform | Get Alert |
| 09/19/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $341.62 | -4.87% | Liisa Bayko70% | $325 → $325 | Maintains | Outperform | Get Alert |
| 09/13/2023 | AKRO | Buy Now | Akero Therapeutics | $44.94 | 33.51% | Liisa Bayko70% | $50 → $60 | Maintains | Outperform | Get Alert |
| 09/06/2023 | TVTX | Buy Now | Travere Therapeutics | $20.55 | 45.99% | Liisa Bayko70% | → $30 | Reinstates | Outperform → Outperform | Get Alert |
| 08/01/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -51.23% | Liisa Bayko70% | → $245 | Maintains | Outperform | Get Alert |
| 07/06/2023 | CARM | Buy Now | CARISMA Therapeutics | $0.42 | 2786% | Liisa Bayko70% | → $12 | Initiates | → Outperform | Get Alert |
| 06/26/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -24.55% | Liisa Bayko70% | $375 → $379 | Maintains | Outperform | Get Alert |
| 06/13/2023 | ETNB | Buy Now | 89bio | $8.53 | 474.44% | Liisa Bayko70% | → $49 | Initiates | → Outperform | Get Alert |
| 06/06/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.18 | 104.19% | Liisa Bayko70% | $60 → $80 | Upgrade | In-Line → Outperform | Get Alert |
| 05/02/2023 | TVTX | Buy Now | Travere Therapeutics | $20.55 | 26.52% | Liisa Bayko70% | $36 → $26 | Maintains | Outperform | Get Alert |
| 04/20/2023 | BCRX | Buy Now | BioCryst Pharma | $7.99 | 25.16% | Liisa Bayko70% | $13 → $10 | Maintains | Outperform | Get Alert |
| 03/28/2023 | ATXS | Buy Now | Astria Therapeutics | $6.41 | 180.81% | Liisa Bayko70% | → $18 | Initiates | → Outperform | Get Alert |
| 01/18/2023 | ALT | Buy Now | Altimmune | $5.77 | 333.23% | Liisa Bayko70% | $14 → $25 | Maintains | Outperform | Get Alert |
| 12/20/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $341.62 | -4.87% | Liisa Bayko70% | $175 → $325 | Maintains | Outperform | Get Alert |
| 11/02/2022 | BCRX | Buy Now | BioCryst Pharma | $7.99 | 100.25% | Liisa Bayko70% | → $16 | Upgrade | In-Line → Outperform | Get Alert |
| 09/14/2022 | AKRO | Buy Now | Akero Therapeutics | $44.94 | 11.26% | Liisa Bayko70% | $10 → $50 | Upgrade | In-Line → Outperform | Get Alert |
| 08/05/2022 | BCRX | Buy Now | BioCryst Pharma | $7.99 | 75.22% | Liisa Bayko70% | → $14 | Downgrade | Outperform → In-Line | Get Alert |
| 08/01/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.18 | 53.14% | Liisa Bayko70% | $95 → $60 | Downgrade | Outperform → In-Line | Get Alert |
| 07/06/2022 | ENTA | Buy Now | Enanta Pharma | $6.31 | 882.57% | Liisa Bayko70% | → $62 | Upgrade | In-Line → Outperform | Get Alert |
| 06/23/2022 | CRSP | Buy Now | CRISPR Therapeutics | $41.35 | 45.1% | Liisa Bayko70% | $66 → $60 | Downgrade | Outperform → In-Line | Get Alert |
| 06/01/2022 | ENTA | Buy Now | Enanta Pharma | $6.31 | 518.07% | Liisa Bayko70% | → $39 | Upgrade | Underperform → In-Line | Get Alert |
| 05/24/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -44.66% | Liisa Bayko70% | $278 → $278 | Maintains | Outperform | Get Alert |
| 05/10/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $341.62 | -48.77% | Liisa Bayko70% | → $175 | Maintains | Outperform | Get Alert |
| 05/09/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -44.66% | Liisa Bayko70% | $278 → $278 | Maintains | Outperform | Get Alert |
| 05/03/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -44.66% | Liisa Bayko70% | $278 → $278 | Maintains | Outperform | Get Alert |
| 04/19/2022 | ANTX | Buy Now | AN2 Therapeutics | $1.39 | 1698.56% | Liisa Bayko70% | → $25 | Initiates | → Outperform | Get Alert |
| 04/01/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -44.66% | Liisa Bayko70% | $265 → $278 | Maintains | Outperform | Get Alert |
| 03/24/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -47.25% | Liisa Bayko70% | $265 → $265 | Maintains | Outperform | Get Alert |
| 01/31/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $341.62 | -41.75% | Liisa Bayko70% | $199 → $199 | Maintains | Outperform | Get Alert |
| 12/22/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -47.25% | Liisa Bayko70% | → $265 | Maintains | Outperform | Get Alert |
| 12/20/2021 | MDGL | Buy Now | Madrigal Pharmaceuticals | $341.62 | -41.75% | Liisa Bayko70% | $199 → $199 | Maintains | Outperform | Get Alert |
| 11/23/2021 | AURA | Buy Now | Aura Biosciences | $7.50 | 366.67% | Liisa Bayko70% | → $35 | Initiates | → Outperform | Get Alert |
| 11/17/2021 | MDGL | Buy Now | Madrigal Pharmaceuticals | $341.62 | -41.75% | Liisa Bayko70% | → $199 | Maintains | Outperform | Get Alert |
| 08/05/2021 | EDIT | Buy Now | Editas Medicine | $1.31 | 4480.15% | Liisa Bayko70% | $20 → $60 | Upgrade | Underperform → Outperform | Get Alert |
| 07/26/2021 | AVTE | Buy Now | Aerovate Therapeutics | $2.52 | 1090.48% | Liisa Bayko70% | → $30 | Initiates | → Outperform | Get Alert |
| 06/08/2021 | VERA | Buy Now | Vera Therapeutics | $27.50 | -12.73% | Liisa Bayko70% | → $24 | Initiates | → Outperform | Get Alert |
| 05/06/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.18 | 267.53% | Liisa Bayko70% | → $144 | Upgrade | In-Line → Outperform | Get Alert |
| 05/03/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -48.24% | Liisa Bayko70% | → $260 | Maintains | Outperform | Get Alert |
| 03/18/2021 | TBIO | Buy Now | Telesis Bio | $0.48 | 4274.54% | Liisa Bayko70% | → $378 | Downgrade | Outperform → In-Line | Get Alert |
| 11/24/2020 | TBPH | Buy Now | Theravance Biopharma | $9.39 | 219.49% | Liisa Bayko70% | → $30 | Reinstates | → Outperform | Get Alert |
| 11/24/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.18 | 180.76% | Liisa Bayko70% | → $110 | Reinstates | → In-Line | Get Alert |
| 11/24/2020 | MDGL | Buy Now | Madrigal Pharmaceuticals | $341.62 | -47.31% | Liisa Bayko70% | → $180 | Reinstates | → Outperform | Get Alert |
| 11/24/2020 | ENTA | Buy Now | Enanta Pharma | $6.31 | 375.44% | Liisa Bayko70% | → $30 | Initiates | → Underperform | Get Alert |
| 11/24/2020 | BCRX | Buy Now | BioCryst Pharma | $7.99 | 50.19% | Liisa Bayko70% | → $12 | Initiates | → Outperform | Get Alert |
| 04/30/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -43.27% | Liisa Bayko70% | $255 → $285 | Maintains | Market Outperform | Get Alert |
| 03/18/2020 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Liisa Bayko70% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 02/05/2020 | ABUS | Buy Now | Arbutus Biopharma | $3.28 | 204.88% | Liisa Bayko70% | → $10 | Upgrade | Market Perform → Market Outperform | Get Alert |
| 02/03/2020 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Liisa Bayko70% | $40 → $44 | Maintains | Market Outperform | Get Alert |
| 11/06/2019 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.18 | 104.19% | Liisa Bayko70% | $82 → $80 | Maintains | Market Outperform | Get Alert |
| 08/14/2019 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $23.36 | 49.83% | Liisa Bayko70% | $44 → $35 | Maintains | Market Outperform | Get Alert |
| 06/13/2019 | SVRA | Buy Now | Savara | $2.86 | — | Liisa Bayko70% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/12/2019 | EDIT | Buy Now | Editas Medicine | $1.31 | — | Liisa Bayko70% | — | Initiates | → Outperform | Get Alert |
| 01/30/2019 | ICPT | Buy Now | Intercept Pharma | — | — | Liisa Bayko70% | → $175 | Upgrade | Market Perform → Market Outperform | Get Alert |
| 09/17/2018 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $23.36 | 88.36% | Liisa Bayko70% | $33 → $44 | Maintains | Market Outperform | Get Alert |
| 08/09/2018 | SBBP | Buy Now | Strongbridge Biopharma | — | — | Liisa Bayko70% | $10 → $16 | Maintains | Market Outperform | Get Alert |
| 02/13/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -58% | Liisa Bayko70% | $200 → $211 | Maintains | Market Outperform | Get Alert |
| 10/04/2017 | ICPT | Buy Now | Intercept Pharma | — | — | Liisa Bayko70% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 09/11/2017 | SVRA | Buy Now | Savara | $2.86 | 599.3% | Liisa Bayko70% | → $20 | Initiates | → Market Outperform | Get Alert |
| 08/23/2017 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.18 | 104.19% | Liisa Bayko70% | $90 → $80 | Maintains | Market Outperform | Get Alert |
| 07/11/2017 | ENTA | Buy Now | Enanta Pharma | $6.31 | — | Liisa Bayko70% | — | Upgrade | Market Perform → Market Outperform | Get Alert |
| 05/19/2017 | SBPH | Buy Now | Spring Bank | — | — | Liisa Bayko70% | → $20 | Initiates | → Market Perform | Get Alert |
| 03/17/2017 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | — | Liisa Bayko70% | — | Upgrade | Market Perform → Market Outperform | Get Alert |
| 01/31/2017 | OCRX | Buy Now | Ocera Therapeutics | — | — | Liisa Bayko70% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 06/08/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.18 | 114.4% | Liisa Bayko70% | $80 → $84 | Maintains | Market Outperform | Get Alert |
| 05/31/2016 | ICPT | Buy Now | Intercept Pharma | — | — | Liisa Bayko70% | → $200 | Maintains | Market Outperform | Get Alert |
| 07/30/2015 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -70.54% | Liisa Bayko70% | $145 → $148 | Maintains | Market Outperform | Get Alert |
| 07/09/2015 | RARE | Buy Now | Ultragenyx Pharmaceutical | $39.18 | 203.73% | Liisa Bayko70% | → $119 | Initiates | → Outperform | Get Alert |
| 10/29/2014 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -73.52% | Liisa Bayko70% | $115 → $133 | Maintains | Market Outperform | Get Alert |
| 10/28/2014 | VRTX | Buy Now | Vertex Pharmaceuticals | $502.35 | -73.52% | Liisa Bayko70% | $115 → $133 | Maintains | Market Perform | Get Alert |
| 06/11/2014 | OCRX | Buy Now | Ocera Therapeutics | — | — | Liisa Bayko70% | → $15 | Initiates | → Market Outperform | Get Alert |
